Altered Glutamate Neurotransmission and Behaviour in Dementia: Evidence from Studies of Memantine

E-ISSN： 1874-4702|2|1|77-82

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.2, Iss.1, 2009-01, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine in dementia: a review of the current evidence

By Herrmann Nathan Li Abby Lanctôôt Krista

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 787-800

Informa Healthcare

Access to resources Recommend Favorite

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1568-1579

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of memantine for neuroprotection in dementia

By Jain K.K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1397-1406

Informa Healthcare

Access to resources Recommend Favorite

Treatment of dementia with neurotransmission modulation

By Doggrell Sheila A Evans Suzanne

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1633-1654

Informa Healthcare

Access to resources Recommend Favorite

Memantine: Its Role in Vascular Dementia

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 449-456

Bentham Science Publishers

Access to resources Recommend Favorite